share_log

Inozyme Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Patrick G. Enright(9.9%),Juliet Tammenoms Bakker(9.9%), etc.

SEC announcement ·  Aug 11, 2023 16:08
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more